Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
183319-69-9
Purity
95%
Erlotinib Hydrochloride inhibits purified EGFR kinase. Erlotinib is used in the treatment of non-small cell lung cancer, pancreatic cancer and several other types of cancer.
Properties
Name
Erlotinib hydrochloride
Smiles
Cl.COCCOC=1C=C2N=CN=C(NC=3C=CC=C(C#C)C3)C2=CC1OCCOC
Targets
Please log in to see this information
OSI-744 | OSI-774 | erlotinib | erlotinib HCl | erlotinib hydrochloride | erlotinib monohydrochloride | tarceva
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
OSI-744 | OSI-774 | erlotinib | erlotinib HCl | erlotinib hydrochloride | erlotinib monohydrochloride | tarceva
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:183321-74-6
0